We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – News and Features

News

Researchers Discover new Battleground for Viruses and Immune Cells

An improved understanding of how the immune system operates during a viral infection is critical to designing successful anti-virus vaccines, scientists say.
News

Therapeutic DNA Vaccine Delivery via Inovio’s Electroporation Technology Featured in Nature Reviews Cancer

Scientific paper “DNA vaccines: precision tools for activating effective immunity against cancer” now available in the February 2008 issue of Nature Reviews Cancer.
News

Eden Biodesign and iQur Sign Deal to Develop a Combined Vaccine to Treat Hepatitis A and B

Eden Biodesign will develop a bio-manufacturing process to achieve optimal product quality in line with cost of goods parameters before proceeding with clinical trial cGMP manufacture.
News

Emergent BioSolutions and Ninebio Sdn. Bhd. Announce Joint Venture in Malaysia

Newly formed company to focus on creating critical R&D and manufacturing infrastructure and supplying biodefense countermeasures within Asia and other territories.
News

Ebola Virus Disarmed by Excising a Single Gene

Researchers have figured out a way to genetically disarm the virus and making the agent safe to study under conditions far less stringent than those currently imposed.
News

VGX Pharmaceuticals Submits Device Master File to FDA for CELLECTRA™ Electroporator

The Company has been developing the CELLECTRA™ electroporator as its lead clinical medical device for delivering DNA vaccine and therapy products.
News

NIDDK Scientists Detect new Epitope on HIV-1 Protein gp41 Using AbD Serotec-generated Recombinant Mini-antibody

AbD Serotec has announced the publication of a scientific research paper in Journal of Virology from one of its customers.
News

CLC bio Provides Bioinformatics Solution for Vaccine Target Development to ACE BioSciences

CLC bio will upgrade and expand ACE’s bioinformatics platform to the most up-to-date and relevant software, including protein vaccine target characterization.
News

ImmunoVaccine Technologies to Acquire Immunotope

The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
News

ImmunoVaccine Technologies Completes Scale-Up of VacciMax® to Commercially Relevant Scale

The work validates the suitability of the platform for commercial applications in therapeutic cancer and infectious disease indications.
Advertisement